Company
Every investor coverage indicates participated in a round AbbVie raised.
Companies AbbVie acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming AbbVie. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Biotech Paradigm Biopharmaceuticals appoints rheumatology specialist Daniel Furtner as chief medical officer; predecessor Donna Skerrett stays as senior scientific advisor, and the firm's late-stage osteoarthritis trial has finished enrolling 538 participants.
Sydney clinical trials platform HealthMatch raised a $10 million Series C led by Folklore Ventures with Square Peg participating, after laying off half its staff in June; funds will support rehiring and US expansion.
Also SmartCompany·Techboard